155 related articles for article (PubMed ID: 38040191)
1. Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigen.
Johnson L; Bartlett ML; Ramirez F; Heger CD; Smith DR
J Immunol Methods; 2024 Jan; 524():113586. PubMed ID: 38040191
[TBL] [Abstract][Full Text] [Related]
2. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
[TBL] [Abstract][Full Text] [Related]
3. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
4. Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays.
Yun S; Ryu JH; Jang JH; Bae H; Yoo SH; Choi AR; Jo SJ; Lim J; Lee J; Ryu H; Cho SY; Lee DG; Lee J; Kim SC; Park YJ; Lee H; Oh EJ
Ann Lab Med; 2021 Nov; 41(6):577-587. PubMed ID: 34108285
[TBL] [Abstract][Full Text] [Related]
5. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
6. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J
J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
[TBL] [Abstract][Full Text] [Related]
8. Evaluation Protocol for SARS-CoV-2 Serological Assays.
Gededzha MP; Jugwanth S; Mampeule N; Zwane N; David A; Scott L; Stevens W; Mayne ES
Methods Mol Biol; 2022; 2511():307-319. PubMed ID: 35838970
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.
Montesinos I; Gruson D; Kabamba B; Dahma H; Van den Wijngaert S; Reza S; Carbone V; Vandenberg O; Gulbis B; Wolff F; Rodriguez-Villalobos H
J Clin Virol; 2020 Jul; 128():104413. PubMed ID: 32403010
[TBL] [Abstract][Full Text] [Related]
10. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
Front Immunol; 2020; 11():609242. PubMed ID: 33424863
[TBL] [Abstract][Full Text] [Related]
12. Capillary flow-driven immunoassay platform for COVID-19 antigen diagnostics.
Link JS; Carrell CS; Jang I; Barstis EJO; Call ZD; Bellows RA; O'Donnell-Sloan JJ; Terry JS; Anderson LBR; Panraksa Y; Geiss BJ; Dandy DS; Henry CS
Anal Chim Acta; 2023 Oct; 1277():341634. PubMed ID: 37604607
[TBL] [Abstract][Full Text] [Related]
13. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
[TBL] [Abstract][Full Text] [Related]
14. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
[TBL] [Abstract][Full Text] [Related]
15. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).
Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG
Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min.
Lin Q; Wen D; Wu J; Liu L; Wu W; Fang X; Kong J
Anal Chem; 2020 Jul; 92(14):9454-9458. PubMed ID: 32615038
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
[TBL] [Abstract][Full Text] [Related]
18. High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity.
Styer LM; Hoen R; Rock J; Yauney E; Nemeth K; Bievenue R; Parker MM
Microbiol Spectr; 2021 Sep; 9(1):e0013421. PubMed ID: 34319133
[TBL] [Abstract][Full Text] [Related]
19. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
20. Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays.
Mafi S; Rogez S; Darreye J; Alain S; Hantz S
Diagn Microbiol Infect Dis; 2023 Apr; 105(4):115900. PubMed ID: 36716586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
